Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine as Adjuvant Analgesic After Laparoscopic Myomectomy
ChiCTR2600127146Phase 4Recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in Fibromyoma (LM) (2 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: Visual Analogue Scale pain score. Started Jun 2026; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2600127146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127146.